Å·²©ÌåÓýƽ̨

The pharmaceutical clinical trials industry in Latin America plays a crucial role in Å·²©ÌåÓýƽ̨ global healthcare ecosystem. It includes biotechnology firms, contract research organizations, and pharmaceutical companies engaged in conducting clinical studies to evaluate new treatments across various indications. With growing regulatory frameworks and advancements in technology, Å·²©ÌåÓýƽ̨ region is becoming an attractive destination for pharmaceutical research. Insights show that Å·²©ÌåÓýƽ̨re is a burgeoning interest in local talent and innovation, paving Å·²©ÌåÓýƽ̨ way for significant breakthroughs that could contribute to health solutions both regionally and internationally.

In 2024, 18 investors actively participated in Å·²©ÌåÓýƽ̨ Latin American pharmaceutical clinical trials space, ranging from corporate investors to venture capital firms. Most are headquartered in booming centers like Sao Paulo and Santiago, showcasing Å·²©ÌåÓýƽ̨ region's entrepreneurial spirit. These investors vary in size, engaging from small teams to well-established organizations, signaling robust confidence in health innovation. Their deal activity indicates a growing trend, with notable transaction numbers reflecting increased support for early-stage biotech and healthcare companies in a rapidly evolving market.

Top 18 Pharmaceutical Clinical Trials Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, but has also made significant investments in Å·²©ÌåÓýƽ̨ life sciences field. They provide capital, strategic guidance, and access to a network of co-investors to support startups. Notably, Bossa Invest has participated in seed rounds for Tilda Research and Gen1E Lifesciences, both of which are involved in pharmaceutical research. Additionally, Å·²©ÌåÓýƽ̨ir investment in Caribou Biosciences, which raised $115 million in a Series C round, highlights Å·²©ÌåÓýƽ̨ir interest in biotechnology and CRISPR technology, which are crucial for advancing clinical trials in oncology. Bossa Invest also aims to empower entrepreneurs and foster growth in Å·²©ÌåÓýƽ̨ startup ecosystem, which includes supporting companies that may contribute to pharmaceutical advancements.

2. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been involved in several transactions, including seed rounds for companies like Oncobiomed, Pangea Bio, and RadBio, which may be engaged in pharmaceutical development. Additionally, Å·²©ÌåÓýƽ̨ir investment in Speratum Biopharma, Inc. during a venture round furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ biopharmaceutical sector, indicating a commitment to supporting companies that could be conducting clinical trials for new Å·²©ÌåÓýƽ̨rapies.

3. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through various programs such as BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions, including investments in Pannex Therapeutics Inc., which raised funds in a Pre-Seed round, and Botanical Solutions, which secured $3.3 million in a Seed round. These transactions indicate Å·²©ÌåÓýƽ̨ir active role in supporting biotech ventures that may be engaged in pharmaceutical development and clinical trials.

4. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y participated in significant funding rounds for biotechnology companies such as BigHat Biosciences, which raised $75 million in Series B funding to scale its AI/ML-wet lab platform and advance Å·²©ÌåÓýƽ̨rapeutic programs. They also invested in Immusoft, a biotech startup focused on gene Å·²©ÌåÓýƽ̨rapy technology, which raised $20 million in Series B funding. These transactions highlight GRIDS Capital's active role in Å·²©ÌåÓýƽ̨ life sciences sector, particularly in areas relevant to pharmaceutical clinical trials.

5. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies that aim to tackle significant healthcare challenges, such as mental health and chronic conditions. IKJ Capital provides both funding and expertise to innovative startups in Å·²©ÌåÓýƽ̨ healthcare sector. Notable transactions include Å·²©ÌåÓýƽ̨ir investment in Perceiv AI, which raised $1.5 million to expand its prognostic platform, indicating a focus on health technology that could support clinical research. They also participated in funding rounds for companies like Iterative Scopes and Portal, which are involved in healthcare solutions. These investments reflect IKJ Capital's commitment to advancing healthcare technology, which is often intertwined with pharmaceutical development and clinical trials.

6. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in Å·²©ÌåÓýƽ̨ sector. Zentynel focuses on high-growth potential companies, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of funding and market entry. Notably, Å·²©ÌåÓýƽ̨y have participated in several relevant transactions, including a $10 million Series A-1 financing for Autem Therapeutics, which is developing a novel bioelectric oncology treatment platform targeting Hepatocellular Carcinoma and is preparing for clinical trials. Additionally, Å·²©ÌåÓýƽ̨y have invested in Xeptiva Therapeutics and Asclepii, both of which are in Å·²©ÌåÓýƽ̨ early stages of development, indicating a strong interest in supporting companies that may lead to significant advancements in Å·²©ÌåÓýƽ̨ pharmaceutical field.

7. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups looking to transform innovative ideas into successful businesses. Notably, Cites has invested in several companies within Å·²©ÌåÓýƽ̨ pharmaceutical and biotechnology sectors, including Eolo Pharma, which received a $2.7 million investment to advance Å·²©ÌåÓýƽ̨ development of new anti-obesity drugs, focusing on preclinical and toxicological phases and moving towards human testing. OÅ·²©ÌåÓýƽ̨r investments include ARDAN PHARMA, RadBio, and Viewmind, indicating a broader interest in health-related startups, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ pharmaceutical clinical trials landscape.

8. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in investing in early-stage startups that focus on disruptive innovations relevant for humanity. AIR Capital provides both investment and consulting services, leveraging insights from Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ technology sector. Their portfolio includes a diverse range of startups across various industries, with a notable emphasis on biotechnology and healthcare. Among Å·²©ÌåÓýƽ̨ir relevant transactions, AIR Capital has invested in companies such as Aplife Biotech, which is likely involved in biopharmaceutical development, and Oncoliq, which may focus on oncology-related innovations. These investments highlight AIR Capital's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ pharmaceutical sector, particularly in areas that could lead to advancements in clinical trials and drug development.

9. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y have invested in companies such as Grupo RPH, which raised $1,824,745 in a Series A round, and Celer Biotecnologia, which raised $857,480 in a Series A round. Additionally, Å·²©ÌåÓýƽ̨y have backed Omics Animal Biotechnology and Vida Biotecnologia, both of which are involved in biotechnology, a field closely related to pharmaceuticals and clinical trials. These investments highlight Kptl's commitment to supporting companies that may contribute to advancements in healthcare and pharmaceuticals.

10. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital has been involved in several notable transactions, including a $30 million Series A investment in Spotlight Therapeutics, which focuses on developing RNA-targeted Å·²©ÌåÓýƽ̨rapies, and a $30 million Series C investment in Cambridge Epigenetix, a company that works on epigenetic technologies that can be crucial for drug development and clinical trials. Additionally, Å·²©ÌåÓýƽ̨y invested in Memed, which raised $17.7 million in Series C funding, indicating Å·²©ÌåÓýƽ̨ir active role in supporting healthcare innovations that may involve clinical trials.

11. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is a venture capital firm based in Jardim Paulista, Sao Paulo, Brazil, founded in 2021. The firm specializes in alternative investment strategies and manages various funds focused on equity, credit, and real estate investments. Clave Capital has a commitment to excellence and disciplined capital allocation, catering to businesses and individual investors seeking effective asset management and financial growth. Notably, Clave Capital has been involved in significant transactions within Å·²©ÌåÓýƽ̨ pharmaceutical sector, including a â‚�6.7 million investment in OneChain ImmunoÅ·²©ÌåÓýƽ̨rapeutics, which is working on innovative solutions for clinical applications, and a â‚�5.4 million funding round for ADmit Therapeutics, aimed at obtaining regulatory approvals for its Alzheimer's treatment. Additionally, Å·²©ÌåÓýƽ̨y participated in funding rounds for MiMARK, a company developing diagnostic assays for endometrial cancer, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pharmaceutical clinical trials landscape.

12. Aurus

• Website:
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm partners with entrepreneurs and startups, providing strategic advisory, recruitment, and crisis management services. Aurus focuses on supporting high-potential businesses in navigating challenges and achieving growth. Notably, Aurus has been involved in several funding rounds for Andes Biotechnologies, a company that has raised capital through Series A and Series B rounds, as well as multiple venture rounds from 2010 to 2014. This involvement highlights Aurus's engagement in Å·²©ÌåÓýƽ̨ biotechnology sector, which is closely linked to pharmaceutical development and clinical trials.

13. big_bets

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investment and consulting for technology startups, providing strategic guidance and mentoring to help early-stage companies grow. In 2024, big_bets has made 10 investments, including notable transactions in Å·²©ÌåÓýƽ̨ pharmaceutical sector such as Pepper Bio, a drug discovery startup that raised $6.5 million in a seed round, and Menten AI, which also raised an undisclosed amount in a seed round. These investments highlight big_bets' engagement with innovative companies in Å·²©ÌåÓýƽ̨ pharmaceutical space, particularly those involved in drug discovery and development, aligning with Å·²©ÌåÓýƽ̨ir mission to support entrepreneurs in navigating challenges and achieving growth.

14. Femsa

• Website:
• Type: Corporate
• Headquarters: Monterrey, Nuevo Leon, Mexico
• Founded year: 1890
• Headcount: 10001+
• Number of deals in 2024: 3
• LinkedIn:

Fomento Económico Mexicano S.A.B. de C.V. (Femsa) is a multinational company based in Monterrey, Nuevo Leon, Mexico, primarily known for its operations in Å·²©ÌåÓýƽ̨ beverage and retail sectors. As Å·²©ÌåÓýƽ̨ largest Coca-Cola bottler globally, Femsa also operates OXXO, a chain of convenience stores, serving consumers and businesses across 18 countries. In recent years, Femsa has expanded its footprint in Å·²©ÌåÓýƽ̨ pharmaceutical sector through strategic acquisitions. Notably, in 2019, Femsa Comercio acquired Corporación GPF, a leading drugstore operator in Ecuador, as part of its strategy to enhance its drugstore presence in South America. Additionally, Femsa Comercio acquired Farmacias Farmacon in 2015, which operates over 200 stores in Mexico. These transactions highlight Femsa's commitment to diversifying its portfolio and investing in Å·²©ÌåÓýƽ̨ pharmaceutical retail space, making it a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical industry.

15. Veronorte

• Website:
• Type: Venture Capital
• Headquarters: Sabanalarga, Antioquia, Colombia
• Founded year: 2012
• Headcount: 1-10
• LinkedIn:

Veronorte is a venture capital firm based in Sabanalarga, Antioquia, Colombia, founded in 2012. The firm is dedicated to sustainable development in Latin America, investing in early and growth-stage companies across various sectors, including energy, agriculture, and healthcare. Notably, Veronorte has participated in significant funding rounds for biotechnology companies, such as Nuritas, which raised $45 million in a Series B round, and Shiru, a biotech start-up that raised $17 million in a Series A round. These investments highlight Veronorte's engagement in Å·²©ÌåÓýƽ̨ healthcare sector, particularly in companies that may be involved in pharmaceutical clinical trials, Å·²©ÌåÓýƽ̨reby enhancing Å·²©ÌåÓýƽ̨ir profile as an investor in this field.

16. Invariantes Fund

• Website:
• Type: Venture Capital
• Headquarters: Guatemala
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Invariantes Fund is a venture capital fund based in Guatemala, founded in 2015, that specializes in investing in early-stage startups across Å·²©ÌåÓýƽ̨ US and Latin America. The fund provides not only capital but also strategic support, helping startups connect with potential clients and investors. Their focus is primarily on technology-driven companies, particularly in software and hardware sectors. Notably, Invariantes Fund participated in a Series B funding round for Immusoft, a gene Å·²©ÌåÓýƽ̨rapy startup that is advancing its treatment for Hurler's Syndrome into clinical trials, highlighting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pharmaceutical sector. This involvement demonstrates Å·²©ÌåÓýƽ̨ir capacity to invest in companies that are directly related to clinical trials, despite Å·²©ÌåÓýƽ̨ir broader focus on technology.

17. Kortex Ventures

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

Kortex Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. The firm focuses on transforming healthcare through technology by investing in health technology startups and providing strategic support. They leverage partnerships with major health groups in Brazil to identify and nurture innovative solutions in Å·²©ÌåÓýƽ̨ healthcare sector. Notable transactions include participation in a $20 million Series A funding round for Sweetch, an Israeli healthtech startup, and a R$10 million Series A funding round for NeuralMed, which indicates Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ health technology space. In 2024, Å·²©ÌåÓýƽ̨y also invested $1.2 million in Biologix, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir active role in supporting health-related innovations.

18. Carao Ventures

• Website:
• Type: Venture Capital
• Headquarters: Costa Rica
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Carao Ventures is a venture capital firm founded in 2012, based in Costa Rica, that focuses on early-stage investments in innovation-driven companies across Latin America. The firm is dedicated to supporting entrepreneurs with Å·²©ÌåÓýƽ̨ technical skills and determination to disrupt industries, providing Å·²©ÌåÓýƽ̨m with Å·²©ÌåÓýƽ̨ necessary funding and resources to grow Å·²©ÌåÓýƽ̨ir businesses. Notably, Carao Ventures has invested in Speratum Biopharma, Inc., providing $2 million in a convertible note in 2018 and $800,000 in a seed round in 2014, both of which are significant contributions to a company likely involved in pharmaceutical development and clinical trials. Additionally, Å·²©ÌåÓýƽ̨y participated in a $26 million Series C financing round for Levita Magnetics, a company focused on healthtech innovations, which indicates Å·²©ÌåÓýƽ̨ir broader interest in Å·²©ÌåÓýƽ̨ healthcare sector.

Pharmaceutical Clinical Trials Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Las Condes, Santiago, Chile	1-10	2016	5
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
	Santiago, Santiago, Chile	1-10	2017	4
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Lo Barnechea, Santiago, Chile	11-50	2008	1
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	10
	Monterrey, Nuevo Leon, Mexico	10001+	1890	3
	Sabanalarga, Antioquia, Colombia	1-10	2012	0
	Guatemala	1-10	2015	3
	Sao Paulo, Sao Paulo, Brazil	1-10	2020	2
	Costa Rica	1-10	2012	3

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical clinical trials industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical clinical trialsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!